BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 35163216)

  • 1. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
    Yamada S; Asakura H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    Yamada S; Asakura H
    Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of hemostatic and fibrinolytic markers].
    Asakura H
    Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttrauma coagulation and fibrinolysis.
    Gando S; Tedo I; Kubota M
    Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T; Aoki N
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypes of Disseminated Intravascular Coagulation.
    Wada T; Gando S
    Thromb Haemost; 2024 Mar; 124(3):181-191. PubMed ID: 37657485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
    Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation.
    Watanabe R; Wada H; Yamamuro M; Inoue A; Watanabe M; Kumeda K; Sakakura M; Okugawa Y; Nakasaki T; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Nobori T; Shiku H
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):71-7. PubMed ID: 12643327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
    Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.